More on RZLT
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.40 |
|
|||
| Open | $4.55 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $4.55 | ||||
| Day Low | $4.07 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 905,620 | ||||
- FDA continues review of Rezolute's congenital HI drug data
- Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
- Rezolute to Participate in Upcoming Investor Conferences
- Form SCHEDULE 13G/A Rezolute, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
- Form SCHEDULE 13G/A Rezolute, Inc. Filed by: BANK OF AMERICA CORP /DE/
- Form SCHEDULE 13G Rezolute, Inc. Filed by: Dellora Investments LP
- H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
- Rezolute to Participate in the BTIG Virtual Biotechnology Conference
- Form 4 Rezolute, Inc. For: Jul 02 Filed by: ROBERTS BRIAN KENNETH
- Form 4 Rezolute, Inc. For: Jul 02 Filed by: Elam Nevan C
Entities mentioned with RZLT
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- S3 | View Related Stories »
- Show More...
